B-CAG-hCD73 MC38

Basic Information

Strain Name
MC38 Nt5etm2(hNT5E)/Bcgen
Stock Number
310728
Common Name
B-CAG-hCD73 MC38
Disease
Colon carcinoma
Species
Mus musculus, mouse
Growth factors
Adherent
Culture medium
DMEM+10% FBS+1% L-Glutamine+1% NEAA+1% Sodium pyruvate+1%HEPES
Frozen
90% FBS+10% DMSO
Notice
Biocytogen provides engineering service to generate the humanized tumor cell lines from customer’s own cell lines. Our humanized tumor cell lines are for pharmacology services ONLY.

Targeting Strategy

Gene targeting strategy for B-CAG-hCD73 MC38.The exons 2-3 of mouse CD73 gene that the full-length protein domain were replaced by human CD73 CDS region in B-CAG-hCD73 MC38.

Details

Protein expression analysis

The CD73 expression analysis in B-CAG-hCD73 MC38 cells by flow cytometry. Single cells were collected from B-CAG-hCD73 MC38 cells, and analyzed by flow cytometry with species-specific anti-CD73 antibody. Human CD73 was detectable in B-CAG-hCD73 MC38 cells.

Tumor Growth Curve & Body Weight Changes

Subcutaneous xenograft tumor growth of B-CAG-hCD73 MC38 cells. B-CAG-hCD73 MC38 cells and wild-type MC38 cells (5×105) were subcutaneously implanted into the C57BL/6N mice (female, 6-8 week-old, n=5).Tumor size and mice body weight were measured twice a week. (A) Tumor average volume ± SEM, (B) Mice body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5a X b2, where a and b were the long and short diameters of the tumor, respectively. As shown in panel A, B-CAG-hCD73 MC38 were able to establish tumor in vivo and can be used for efficacy study.

Back to top